Anabel Chan | Head, Investor Relations |
Mark Enyedy | President, CEO & Director |
Anna Berkenblit | SVP & Chief Medical Officer |
Susan Altschuller | SVP & CFO |
John Newman | Canaccord Genuity |
Michael Schmidt | Guggenheim Securities |
Etzer Darout | BMO Capital Markets |
Faisal Khurshid | SVB Securities |
Andy Hsieh | William Blair & Company |
Peter Lawson | Barclays Bank |
Arthur He | H.C. Wainwright & Co. |
Boris Peaker | Cowen and Company |
Kelly Shi | Jefferies |
Daniel Wolle | JPMorgan Chase & Co. |
Good morning, and welcome to ImmunoGen's Third Quarter 2022 Financial and Operating Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Anabel Chan, Head of Investor Relations. Please go ahead.
Good morning, and thank you for joining today's call.